A fecal occult blood test (FOBT) checks your stool for tiny amounts of blood that you can’t see with the naked eye. “Occult” simply means hidden. The test is one of the most common ways to screen for colorectal cancer, and it’s recommended annually for adults ages 45 to 75. You collect the sample at home, which makes it one of the simpler cancer screening tools available.
In a healthy digestive tract, you lose about 0.5 to 1.5 milliliters of blood per day, which is too little for these tests to pick up. When bleeding increases beyond that baseline, whether from a polyp, a tumor, or something entirely benign like hemorrhoids, the test flags it.
How the Two Test Types Work
There are two main versions of this test, and they detect different parts of blood. The older type, called the guaiac-based test (gFOBT), detects heme, the iron-containing molecule inside red blood cells. When heme is present on the test card, it triggers a chemical reaction that turns a plant-based compound called guaiac blue. That color change signals a positive result.
The newer version, the fecal immunochemical test (FIT), works differently. It uses antibodies that latch onto the protein portion of hemoglobin (called globin) rather than the iron portion. This distinction matters for one important reason: globin gets broken down quickly as it passes through the stomach and small intestine. By the time stool reaches the colon, only blood originating from the lower digestive tract still has intact globin. That makes FIT far more specific to colon and rectal bleeding, which is exactly where colorectal cancers develop. The guaiac test, by contrast, can pick up bleeding from anywhere in the digestive tract, including the stomach or esophagus.
FIT has largely replaced the guaiac test in routine screening because of this selectivity and because it requires less preparation from the patient.
How Accurate Is It?
No stool-based test can diagnose cancer on its own, but FIT is reasonably good at catching it. A large meta-analysis found that FIT detects colorectal cancer with a sensitivity ranging from about 71% to 91%, depending on the specific test brand and the cutoff used. Specificity, meaning the ability to correctly identify people who don’t have cancer, ranges from 90% to 95%.
The test’s ability to catch cancer also depends on how advanced it is. Pooled data show sensitivity of about 73% for stage I cancers and roughly 80% to 82% for stages II and III. Very early, small growths that haven’t yet invaded deeply into the colon wall (called T1 tumors) are harder to catch, with sensitivity dropping to around 40%. This is one reason the test is meant to be repeated every year. A polyp or early tumor that doesn’t bleed enough to trigger a positive result during one round of testing may bleed enough the next time.
Collecting Your Sample at Home
Both tests come with a kit you use at home. The basic process is straightforward: you collect a bowel movement (the kit may include special paper to catch it over the toilet, or you can use plastic wrap or a clean container), then use a stick or brush to scrape a small sample. Depending on the kit, you either smear the sample onto a test card or insert the brush into a collection tube. You label it, seal it, and either mail it back or bring it to your provider’s office.
A guaiac test typically requires samples from two or three separate bowel movements. FIT requires one to three, depending on the brand. Collecting over multiple days increases the chance of catching intermittent bleeding.
Preparation for Each Test Type
FIT requires little to no dietary preparation, which is a major practical advantage. Because it uses antibodies specific to human hemoglobin, food and most medications don’t interfere with results.
The guaiac test is more finicky. Because it reacts to any substance with a similar chemical activity to heme, certain foods and supplements can trigger a false positive or mask a true positive. Most guaiac test manufacturers recommend avoiding red meat for two to three days before and during collection. Some brands also call for avoiding high-peroxidase fruits and vegetables like turnips, horseradish, and melon. Certain medications and vitamin C supplements can also affect results. Your provider or the kit instructions will specify exactly what to skip and for how long.
What a Positive Result Means
A positive result means blood was detected in your stool. It does not mean you have cancer. Many common, noncancerous conditions cause hidden bleeding in the digestive tract: hemorrhoids, anal fissures, stomach ulcers, inflammatory bowel disease, and even swallowed blood from a nosebleed. With the guaiac test, dietary sources can also cause a false positive if preparation instructions weren’t followed carefully.
Still, a positive result needs to be investigated. The standard next step is a colonoscopy, which allows a gastroenterologist to visually examine the entire colon and remove any polyps found during the procedure. Programs with the best outcomes get patients to colonoscopy within three months of a positive FIT result, though guidelines generally recommend completing it within a year. Skipping the follow-up colonoscopy eliminates most of the benefit of having done the screening in the first place.
What a Negative Result Means
A negative result means no blood was detected at the time of collection. That’s reassuring, but it isn’t a guarantee that nothing is there. Polyps and early cancers don’t bleed continuously. A tumor might bleed one day and not the next, so a single negative test can miss an existing problem. This is exactly why annual testing is recommended. Each yearly test is another opportunity to catch bleeding that was absent or below the detection threshold on the previous round. Over several years of consistent annual testing, the cumulative chance of catching a significant problem rises substantially.
FOBT vs. Colonoscopy
The two are not competing options so much as different tiers of screening. A colonoscopy examines the colon directly and can both find and remove polyps in a single procedure, which is why it only needs to be done every 10 years for average-risk individuals. An FOBT is less invasive, requires no sedation, and can be done at home, but it needs to be repeated every year and can only flag that something might be wrong. If it comes back positive, you’ll need a colonoscopy anyway.
For people who are up to date with annual FOBT or FIT testing, the screening benefit over time is substantial. The key is consistency. A single test done once and never repeated offers limited protection. The real value comes from testing every year so that intermittent or new bleeding gets caught early, when treatment is most effective.